Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024Cancer Research

Abstract 6361: KY-HC-mouse: A low-cost and rapid nanobody discovery platform

View Full Paper
Ask AI
Bookmark
Share

Authors

GWGuojin WuFHFeng HaoFHFeng He

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wu et al. (2024) studied this question.

synapsesocial.com/papers/68e72ce5b6db6435876a6dd2https://doi.org/10.1158/1538-7445.am2024-6361
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 5391: A versatile KY-HC-mouse™nanobody platform enabling tumor-anchored, conditionally active 4-1BB bispecific antibodies2026
  2. 2Abstract 2382: KY-CLC-mouse: a common light chain bispecific antibody discovery platform2024
  3. 3Abstract 5851: (Common-light-chain-antibody+nano-body) × multi-matrix-immunization platform facilitates the development of antitumor multispecific antibody drugs2026
  4. 4Abstract 5333: NeoMab: A novel platform for fully human therapeutic antibody development2024
  5. 5Abstract 1647: RenNano platform enables efficient discovery of fully human VHH antibodies2026